Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.
about
Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersA place for precision medicine in bladder cancer: targeting the FGFRs.Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosisPredicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis.A Hidden Markov Model to estimate population mixture and allelic copy-numbers in cancers using Affymetrix SNP arrays.FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancerBioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder.Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.Urothelial carcinoma: stem cells on the edge.Deregulation of Rab and Rab effector genes in bladder cancer.A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR.Bladder cancer detection and monitoring: assessment of urine- and blood-based marker testsExpression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patientsRole of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic targetSignal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival.Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptors.Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer.Bladder cancer subtypes defined by genomic alterations.Gene signatures for risk-adapted treatment of bladder cancer.How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients.Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urotheliaHigh throughput molecular diagnostics in bladder cancer - on the brink of clinical utility.Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-upTargeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy.Fibroblast growth factors and their receptors in cancer.Immunohistochemical biomarkers for bladder cancer prognosis.The relationship of cancer stem cells in urological cancers.Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.Molecular markers in bladder cancer: Novel research frontiers.Transcription Factor KLF5 Binds a Cyclin E1 Polymorphic Intronic Enhancer to Confer Increased Bladder Cancer RiskNext-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis.Are microRNAs located in genomic regions associated with cancer?Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in miceFibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer.Non-invasive papillary urothelial carcinoma of the vagina: molecular analysis of a rare case identifies clonal relationship to non-invasive urothelial carcinoma of the bladder.
P2860
Q26998955-0F851767-90AB-4554-BA5E-7A1F310D98A2Q30249143-C684A4AE-3A99-48E2-9D49-1EDEAD6F6315Q30439612-9366B984-AB6B-4E43-9ACB-20969F767B3DQ30446429-58ACD0BE-DFBB-4835-9C16-E86A58B95472Q30837295-12FCBED3-044E-4062-AB73-A94D3E4EF9F1Q33292711-6F532F7C-2993-422B-A884-3C7AA175CF6BQ33317632-9DB5357E-4830-4D1E-A87D-2948CCEB73F0Q33349898-ED77AC4D-408C-443A-B3AF-45B786CDFCE3Q34092411-500D738E-F90F-4858-BFEC-2BA6EFF8817DQ34314461-D1F7078B-4A63-44F9-AA37-8E3D3A862F8FQ34524813-4EFFDC9A-8149-42CB-A522-3B97CCDBD718Q36190604-9AA7A098-5638-472B-B3F0-87EF043104F0Q36387801-18639001-C241-4831-9215-E796EC551A89Q36770389-7303313E-6E3C-4F58-9463-4AE1CCC7B13BQ36879739-46867F95-3A3C-40B2-95F0-01CEF61DFFE8Q36958930-9FB2155C-6273-4539-81FE-7B82A2DE2E78Q36960662-9B816504-BB5C-4831-9900-9EB2971A095DQ37074139-5B3500CF-01E5-4221-85FB-90DA5D310434Q37227743-590E4D55-20BF-47A4-A0E9-B08DB4FC7CC7Q37278990-62DC6039-BD03-41BB-979C-4EB2076E0E8CQ37279004-6FE2F3AD-ABE2-4C7B-BA4B-EC281B59B79EQ37279006-80F8C54F-99BF-4134-99EC-1658E74F035DQ37295512-E4B5F450-070D-4A42-A800-6F42E9222B05Q37311457-2F7D5A2C-FFE3-4EF3-95CB-A9CB6699EE93Q37453816-CE867B97-CFC3-47F3-9157-B759A736441BQ37687183-3E1A3413-561C-43CE-8A17-E49F6B827AAFQ37849781-87F77324-A04A-43F3-9307-7F7D9469E9FEQ37895306-507CCBFF-C8A8-4D42-9615-2570734AEB4CQ37902697-10B0F406-27BC-46C6-8B0E-E3371C07A2DDQ38202644-377EBD51-963C-42A7-88B3-D803B3882C68Q38297729-DBAF564B-3D7F-469A-88EB-B3CB07BFA8C0Q38520403-100917F0-3347-4894-AB7B-7A65BAFFA208Q38752422-13DADEFF-C95F-4D79-B53D-492926A8C4C2Q40275671-B737EDE3-9284-4564-81BD-8E7C5CBCE2B2Q41584915-E68E309F-FE65-45B1-8131-AAD9248AFD7FQ41819551-3414A491-FF28-4AFD-B183-4E0BA24C69B0Q42214617-DC8F3FFF-CDFE-42AF-A8C1-ECD356E44B50Q42738385-74863E1D-F2D3-4B9E-ADB8-73CBAFAAF548Q43148228-514B9401-2792-49AF-BA83-4C7233B64F1EQ47738905-6FAD7B68-40B1-4081-8921-B5D0541A992A
P2860
Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Role of activating fibroblast ...... development of bladder tumors.
@en
Role of activating fibroblast ...... development of bladder tumors.
@nl
type
label
Role of activating fibroblast ...... development of bladder tumors.
@en
Role of activating fibroblast ...... development of bladder tumors.
@nl
prefLabel
Role of activating fibroblast ...... development of bladder tumors.
@en
Role of activating fibroblast ...... development of bladder tumors.
@nl
P2093
P50
P1476
Role of activating fibroblast ...... development of bladder tumors.
@en
P2093
Jens L Jensen
Karsten Zieger
Klaus Møller-Ernst Jensen
Torben Falck Ørntoft
P304
P356
10.1158/1078-0432.CCR-05-1130
P407
P577
2005-11-01T00:00:00Z